Clinical Trial Update: A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2a randomized, placebo-controlled trial evaluating safety and efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• AMG 557
• MEDI5872 (MEDI5872)

Snippet

Sponsor: MedImmune LLC | Conditions: Primary Sjögren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-03-19